Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-06

AUTHORS

Moneeza K. Siddiqui, Gwen Kennedy, Fiona Carr, Alexander S. F. Doney, Ewan R. Pearson, Andrew D. Morris, Toby Johnson, Megan M. McLaughlin, Rachel E. Williams, Colin N. A. Palmer

ABSTRACT

AIMS/HYPOTHESIS: The aim of the study was to examine the association between lipoprotein-associated phospholipase A2 (Lp-PLA2) activity levels and incident diabetic retinopathy and change in retinopathy grade. METHODS: This was a cohort study of diabetic participants with serum collected at baseline and routinely collected diabetic retinal screening data. Participants with type 2 diabetes from the GoDARTS (Genetics of Diabetes Audit and Research in Tayside Scotland) cohort were used. This cohort is composed of individuals of white Scottish ancestry from the Tayside region of Scotland. Survival analysis accounting for informative censoring by modelling death as a competing risk was performed for the development of incident diabetic retinopathy from a disease-free state in a 3 year follow-up period (n = 1364) by stratified Lp-PLA2 activity levels (in quartiles). The same analysis was performed for transitions to more severe grades. RESULTS: The hazard of developing incident diabetic retinopathy was 2.08 times higher (95% CI 1.64, 2.63) for the highest quartile of Lp-PLA2 activity compared with the lowest. Higher Lp-PLA2 activity levels were associated with a significantly increased risk for transitions to all grades. The hazards of developing observable (or more severe) and referable (or more severe) retinopathy were 2.82 (95% CI 1.71, 4.65) and 1.87 (95% CI 1.26, 2.77) times higher for the highest quartile of Lp-PLA2 activity compared with the lowest, respectively. CONCLUSIONS/INTERPRETATION: Higher Lp-PLA2 levels are associated with increased risk of death and the development of incident diabetic retinopathy, as well as transitions to more severe grades of diabetic retinopathy. These associations are independent of calculated LDL-cholesterol and other traditional risk factors. Further, this biomarker study shows that the association is temporally sensitive to the proximity of the event to measurement of Lp-PLA2. More... »

PAGES

1344-1353

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-018-4601-7

DOI

http://dx.doi.org/10.1007/s00125-018-4601-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103178673

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29623345


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "1-Alkyl-2-acetylglycerophosphocholine Esterase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Retinopathy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electronic Health Records", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Longitudinal Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microcirculation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Scotland", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ninewells Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416266.1", 
          "name": [
            "Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, University of Dundee School of Medicine, Ninewells Hospital and Medical School, DD1 9SY, Dundee, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Siddiqui", 
        "givenName": "Moneeza K.", 
        "id": "sg:person.014222663645.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014222663645.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ninewells Hospital and Medical School, University of Dundee, Dundee, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kennedy", 
        "givenName": "Gwen", 
        "id": "sg:person.0602377336.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602377336.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ninewells Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416266.1", 
          "name": [
            "Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, University of Dundee School of Medicine, Ninewells Hospital and Medical School, DD1 9SY, Dundee, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carr", 
        "givenName": "Fiona", 
        "id": "sg:person.0723764061.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723764061.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ninewells Hospital and Medical School, University of Dundee, Dundee, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doney", 
        "givenName": "Alexander S. F.", 
        "id": "sg:person.010200751534.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010200751534.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ninewells Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416266.1", 
          "name": [
            "Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, University of Dundee School of Medicine, Ninewells Hospital and Medical School, DD1 9SY, Dundee, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pearson", 
        "givenName": "Ewan R.", 
        "id": "sg:person.0666420000.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666420000.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Edinburgh", 
          "id": "https://www.grid.ac/institutes/grid.4305.2", 
          "name": [
            "Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morris", 
        "givenName": "Andrew D.", 
        "id": "sg:person.014366020547.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014366020547.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.418236.a", 
          "name": [
            "GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Johnson", 
        "givenName": "Toby", 
        "id": "sg:person.01242474271.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242474271.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Arkema (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419047.f", 
          "name": [
            "Alternative Discovery and Development, Research & Development, GlaxoSmithKline, King of Prussia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McLaughlin", 
        "givenName": "Megan M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418019.5", 
          "name": [
            "Worldwide Epidemiology, GlaxoSmithKline, Collegeville, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Williams", 
        "givenName": "Rachel E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ninewells Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416266.1", 
          "name": [
            "Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, University of Dundee School of Medicine, Ninewells Hospital and Medical School, DD1 9SY, Dundee, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmer", 
        "givenName": "Colin N. A.", 
        "id": "sg:person.01016372227.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016372227.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ophtha.2010.02.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003458685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2010.02258.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007524624"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2010.02258.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007524624"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(95)30894-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008747998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2005.11.038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008928273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2008.10.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009145982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1993.03510140074032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010028810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1034/j.1600-0420.1999.770211.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012706771"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2007.07.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013261467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.53.11.2883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014324731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1988.03410190112033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018139492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)60319-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020486660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(98)91020-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021744248"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(98)91020-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021744248"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2011.12.039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024267022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1514213113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024434288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(00)00600-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026346280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2011.01.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027031594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2012.04.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029793783"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1076/opep.6.1.61.1563", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030063151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc11-1909", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034742328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.1996.01100140281004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036647745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.eye.6701476", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037499859", 
          "https://doi.org/10.1038/sj.eye.6701476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.eye.6701476", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037499859", 
          "https://doi.org/10.1038/sj.eye.6701476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2005.01603.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038109955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2005.01603.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038109955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200010193431603", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039043506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.9.2653", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040313931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14728214.12.4.591", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045744845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.0000222983.73369.c8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048190623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.0000222983.73369.c8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048190623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2392", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048805500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2014.12.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050307473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007995.2010.482503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051289022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2008.07.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052563999"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1999.10474144", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058305593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076395449", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/003591576505800503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1076395449"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3233/jad-122254", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078686348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ije/dyx140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090564017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ije/dyx140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090564017"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-06", 
    "datePublishedReg": "2018-06-01", 
    "description": "AIMS/HYPOTHESIS: The aim of the study was to examine the association between lipoprotein-associated phospholipase A2 (Lp-PLA2) activity levels and incident diabetic retinopathy and change in retinopathy grade.\nMETHODS: This was a cohort study of diabetic participants with serum collected at baseline and routinely collected diabetic retinal screening data. Participants with type 2 diabetes from the GoDARTS (Genetics of Diabetes Audit and Research in Tayside Scotland) cohort were used. This cohort is composed of individuals of white Scottish ancestry from the Tayside region of Scotland. Survival analysis accounting for informative censoring by modelling death as a competing risk was performed for the development of incident diabetic retinopathy from a disease-free state in a 3\u00a0year follow-up period (n\u2009=\u20091364) by stratified Lp-PLA2 activity levels (in quartiles). The same analysis was performed for transitions to more severe grades.\nRESULTS: The hazard of developing incident diabetic retinopathy was 2.08 times higher (95% CI 1.64, 2.63) for the highest quartile of Lp-PLA2 activity compared with the lowest. Higher Lp-PLA2 activity levels were associated with a significantly increased risk for transitions to all grades. The hazards of developing observable (or more severe) and referable (or more severe) retinopathy were 2.82 (95% CI 1.71, 4.65) and 1.87 (95% CI 1.26, 2.77) times higher for the highest quartile of Lp-PLA2 activity compared with the lowest, respectively.\nCONCLUSIONS/INTERPRETATION: Higher Lp-PLA2 levels are associated with increased risk of death and the development of incident diabetic retinopathy, as well as transitions to more severe grades of diabetic retinopathy. These associations are independent of calculated LDL-cholesterol and other traditional risk factors. Further, this biomarker study shows that the association is temporally sensitive to the proximity of the event to measurement of Lp-PLA2.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00125-018-4601-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3641142", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3629229", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "61"
      }
    ], 
    "name": "Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study", 
    "pagination": "1344-1353", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6686ba5adfa76dba0e1526a00fbb477ce81a276c923d90393ce33a084ad16dba"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29623345"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-018-4601-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103178673"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-018-4601-7", 
      "https://app.dimensions.ai/details/publication/pub.1103178673"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000372_0000000372/records_117125_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00125-018-4601-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-018-4601-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-018-4601-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-018-4601-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-018-4601-7'


 

This table displays all metadata directly associated to this object as RDF triples.

319 TRIPLES      21 PREDICATES      80 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-018-4601-7 schema:about N1e31744b96364435a635a0b0100fd7ed
2 N30f2c394bd8d48efa96e72a172d109be
3 N3d9409f02df440beadd1882a6fc55061
4 N415dc647f4024fe484f5a415ee78ada4
5 N55a34eee473f4da69d380183cc2a74d6
6 N8f5d1feb2b86434b9b3095167771571a
7 N96a64a9ab01649a485f3be967563f730
8 N96f6de5f0be3486784ba2000f37c6938
9 Na85661eab94a45ff817d458d513ed3b0
10 Na93c56e018be43f1908ac4caa9b62bf6
11 Nbed6cc4e44ea4dfa9e591093c2ef08e8
12 Nc7fe1fd6edb24722abd676bae20ba47a
13 Nc92bee1f132d4ba38b9bdb6d177f617c
14 Nd9f7681e9a414a4f91885647e2af05e5
15 Nf52eeac5d3f248069b3000e526472006
16 Nff4aa44c48b3487eb4bcb34561c8d5c8
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N571a8b0fac6e475da067912b7e2e1d1b
20 schema:citation sg:pub.10.1038/sj.eye.6701476
21 https://app.dimensions.ai/details/publication/pub.1076395449
22 https://doi.org/10.1001/archopht.1996.01100140281004
23 https://doi.org/10.1001/jama.1988.03410190112033
24 https://doi.org/10.1001/jama.1993.03510140074032
25 https://doi.org/10.1016/j.ajo.2005.11.038
26 https://doi.org/10.1016/j.ajo.2008.07.024
27 https://doi.org/10.1016/j.jdiacomp.2007.07.005
28 https://doi.org/10.1016/j.ophtha.2008.10.016
29 https://doi.org/10.1016/j.ophtha.2010.02.031
30 https://doi.org/10.1016/j.ophtha.2011.01.031
31 https://doi.org/10.1016/j.ophtha.2011.12.039
32 https://doi.org/10.1016/j.ophtha.2012.04.027
33 https://doi.org/10.1016/j.ophtha.2014.12.014
34 https://doi.org/10.1016/s0140-6736(10)60319-4
35 https://doi.org/10.1016/s0161-6420(00)00600-x
36 https://doi.org/10.1016/s0161-6420(95)30894-9
37 https://doi.org/10.1016/s0161-6420(98)91020-x
38 https://doi.org/10.1034/j.1600-0420.1999.770211.x
39 https://doi.org/10.1056/nejm200010193431603
40 https://doi.org/10.1073/pnas.1514213113
41 https://doi.org/10.1076/opep.6.1.61.1563
42 https://doi.org/10.1080/01621459.1999.10474144
43 https://doi.org/10.1093/ije/dyx140
44 https://doi.org/10.1111/j.1365-2796.2010.02258.x
45 https://doi.org/10.1111/j.1464-5491.2005.01603.x
46 https://doi.org/10.1161/01.atv.0000222983.73369.c8
47 https://doi.org/10.1177/003591576505800503
48 https://doi.org/10.1185/03007995.2010.482503
49 https://doi.org/10.1517/14728214.12.4.591
50 https://doi.org/10.2337/dc11-1909
51 https://doi.org/10.2337/dc12-2392
52 https://doi.org/10.2337/diabetes.53.11.2883
53 https://doi.org/10.2337/diacare.26.9.2653
54 https://doi.org/10.3233/jad-122254
55 schema:datePublished 2018-06
56 schema:datePublishedReg 2018-06-01
57 schema:description AIMS/HYPOTHESIS: The aim of the study was to examine the association between lipoprotein-associated phospholipase A2 (Lp-PLA2) activity levels and incident diabetic retinopathy and change in retinopathy grade. METHODS: This was a cohort study of diabetic participants with serum collected at baseline and routinely collected diabetic retinal screening data. Participants with type 2 diabetes from the GoDARTS (Genetics of Diabetes Audit and Research in Tayside Scotland) cohort were used. This cohort is composed of individuals of white Scottish ancestry from the Tayside region of Scotland. Survival analysis accounting for informative censoring by modelling death as a competing risk was performed for the development of incident diabetic retinopathy from a disease-free state in a 3 year follow-up period (n = 1364) by stratified Lp-PLA2 activity levels (in quartiles). The same analysis was performed for transitions to more severe grades. RESULTS: The hazard of developing incident diabetic retinopathy was 2.08 times higher (95% CI 1.64, 2.63) for the highest quartile of Lp-PLA2 activity compared with the lowest. Higher Lp-PLA2 activity levels were associated with a significantly increased risk for transitions to all grades. The hazards of developing observable (or more severe) and referable (or more severe) retinopathy were 2.82 (95% CI 1.71, 4.65) and 1.87 (95% CI 1.26, 2.77) times higher for the highest quartile of Lp-PLA2 activity compared with the lowest, respectively. CONCLUSIONS/INTERPRETATION: Higher Lp-PLA2 levels are associated with increased risk of death and the development of incident diabetic retinopathy, as well as transitions to more severe grades of diabetic retinopathy. These associations are independent of calculated LDL-cholesterol and other traditional risk factors. Further, this biomarker study shows that the association is temporally sensitive to the proximity of the event to measurement of Lp-PLA2.
58 schema:genre research_article
59 schema:inLanguage en
60 schema:isAccessibleForFree true
61 schema:isPartOf N2cd3d2964f3e400cb0c4a3605353dd56
62 N8bc271a12e0a4d17a632359a5a1c3181
63 sg:journal.1001482
64 schema:name Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
65 schema:pagination 1344-1353
66 schema:productId N26592c219e9742caa91c293fcf488f72
67 N32aea200e34442f69b8b7c467c5910d9
68 N5711d9c69095472bb9c4516a07731a59
69 Nc2f8f30d31d542edaa0125a867d111eb
70 Nd66053bdc48546f8b7b7837b04410659
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103178673
72 https://doi.org/10.1007/s00125-018-4601-7
73 schema:sdDatePublished 2019-04-11T14:21
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher N7b07b7c775cb4791a92cc3cc90b6f1fe
76 schema:url https://link.springer.com/10.1007%2Fs00125-018-4601-7
77 sgo:license sg:explorer/license/
78 sgo:sdDataset articles
79 rdf:type schema:ScholarlyArticle
80 N1e31744b96364435a635a0b0100fd7ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Female
82 rdf:type schema:DefinedTerm
83 N26592c219e9742caa91c293fcf488f72 schema:name pubmed_id
84 schema:value 29623345
85 rdf:type schema:PropertyValue
86 N2cd3d2964f3e400cb0c4a3605353dd56 schema:issueNumber 6
87 rdf:type schema:PublicationIssue
88 N2d2f19a781874c6c9cc6be536b57cd66 rdf:first sg:person.01242474271.34
89 rdf:rest N3589497b55754ac29ecd1869aef8d47b
90 N30d61d7badbf4d8da9b16f091968774b rdf:first sg:person.010200751534.81
91 rdf:rest N6c53923e91f04e93a557f5585471de09
92 N30f2c394bd8d48efa96e72a172d109be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 N32aea200e34442f69b8b7c467c5910d9 schema:name readcube_id
96 schema:value 6686ba5adfa76dba0e1526a00fbb477ce81a276c923d90393ce33a084ad16dba
97 rdf:type schema:PropertyValue
98 N3589497b55754ac29ecd1869aef8d47b rdf:first Nfcf051f0b28e43828d19889f1bd0b662
99 rdf:rest N47cbb7d2b3414126ad40453c3631b966
100 N3d9409f02df440beadd1882a6fc55061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 N415dc647f4024fe484f5a415ee78ada4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Microcirculation
105 rdf:type schema:DefinedTerm
106 N47cbb7d2b3414126ad40453c3631b966 rdf:first N7aea40388a0c411ebcafa5c31df8cb2e
107 rdf:rest Ndb3411e4065142ca8c984d7a5b9292d9
108 N55a34eee473f4da69d380183cc2a74d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Treatment Outcome
110 rdf:type schema:DefinedTerm
111 N5711d9c69095472bb9c4516a07731a59 schema:name nlm_unique_id
112 schema:value 0006777
113 rdf:type schema:PropertyValue
114 N571a8b0fac6e475da067912b7e2e1d1b rdf:first sg:person.014222663645.77
115 rdf:rest N5ff26ab729574f6e9ad14edba39048f4
116 N5ff26ab729574f6e9ad14edba39048f4 rdf:first sg:person.0602377336.44
117 rdf:rest N81a9fe60eaba47aabf33b700211dbc52
118 N6c53923e91f04e93a557f5585471de09 rdf:first sg:person.0666420000.47
119 rdf:rest Nbc40f5daabdc41e7b0c0f308ca1e66a5
120 N7aea40388a0c411ebcafa5c31df8cb2e schema:affiliation https://www.grid.ac/institutes/grid.418019.5
121 schema:familyName Williams
122 schema:givenName Rachel E.
123 rdf:type schema:Person
124 N7b07b7c775cb4791a92cc3cc90b6f1fe schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N81a9fe60eaba47aabf33b700211dbc52 rdf:first sg:person.0723764061.89
127 rdf:rest N30d61d7badbf4d8da9b16f091968774b
128 N8bc271a12e0a4d17a632359a5a1c3181 schema:volumeNumber 61
129 rdf:type schema:PublicationVolume
130 N8f5d1feb2b86434b9b3095167771571a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Electronic Health Records
132 rdf:type schema:DefinedTerm
133 N91e44a3bc7cf40c9976d5d079542a1ca schema:name Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
134 rdf:type schema:Organization
135 N96a64a9ab01649a485f3be967563f730 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Middle Aged
137 rdf:type schema:DefinedTerm
138 N96f6de5f0be3486784ba2000f37c6938 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Diabetes Mellitus, Type 2
140 rdf:type schema:DefinedTerm
141 Na85661eab94a45ff817d458d513ed3b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Aged
143 rdf:type schema:DefinedTerm
144 Na93c56e018be43f1908ac4caa9b62bf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Risk Factors
146 rdf:type schema:DefinedTerm
147 Nbc40f5daabdc41e7b0c0f308ca1e66a5 rdf:first sg:person.014366020547.03
148 rdf:rest N2d2f19a781874c6c9cc6be536b57cd66
149 Nbed6cc4e44ea4dfa9e591093c2ef08e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name 1-Alkyl-2-acetylglycerophosphocholine Esterase
151 rdf:type schema:DefinedTerm
152 Nc2f8f30d31d542edaa0125a867d111eb schema:name doi
153 schema:value 10.1007/s00125-018-4601-7
154 rdf:type schema:PropertyValue
155 Nc7fe1fd6edb24722abd676bae20ba47a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Scotland
157 rdf:type schema:DefinedTerm
158 Nc92bee1f132d4ba38b9bdb6d177f617c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Biomarkers
160 rdf:type schema:DefinedTerm
161 Ncc7675ea185e43a5afd87996c508d6e1 schema:name Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
162 rdf:type schema:Organization
163 Nd66053bdc48546f8b7b7837b04410659 schema:name dimensions_id
164 schema:value pub.1103178673
165 rdf:type schema:PropertyValue
166 Nd9f7681e9a414a4f91885647e2af05e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Disease Progression
168 rdf:type schema:DefinedTerm
169 Ndb3411e4065142ca8c984d7a5b9292d9 rdf:first sg:person.01016372227.74
170 rdf:rest rdf:nil
171 Nf52eeac5d3f248069b3000e526472006 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Longitudinal Studies
173 rdf:type schema:DefinedTerm
174 Nfcf051f0b28e43828d19889f1bd0b662 schema:affiliation https://www.grid.ac/institutes/grid.419047.f
175 schema:familyName McLaughlin
176 schema:givenName Megan M.
177 rdf:type schema:Person
178 Nff4aa44c48b3487eb4bcb34561c8d5c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Diabetic Retinopathy
180 rdf:type schema:DefinedTerm
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
185 schema:name Clinical Sciences
186 rdf:type schema:DefinedTerm
187 sg:grant.3629229 http://pending.schema.org/fundedItem sg:pub.10.1007/s00125-018-4601-7
188 rdf:type schema:MonetaryGrant
189 sg:grant.3641142 http://pending.schema.org/fundedItem sg:pub.10.1007/s00125-018-4601-7
190 rdf:type schema:MonetaryGrant
191 sg:journal.1001482 schema:issn 0012-186X
192 1432-0428
193 schema:name Diabetologia
194 rdf:type schema:Periodical
195 sg:person.01016372227.74 schema:affiliation https://www.grid.ac/institutes/grid.416266.1
196 schema:familyName Palmer
197 schema:givenName Colin N. A.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016372227.74
199 rdf:type schema:Person
200 sg:person.010200751534.81 schema:affiliation N91e44a3bc7cf40c9976d5d079542a1ca
201 schema:familyName Doney
202 schema:givenName Alexander S. F.
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010200751534.81
204 rdf:type schema:Person
205 sg:person.01242474271.34 schema:affiliation https://www.grid.ac/institutes/grid.418236.a
206 schema:familyName Johnson
207 schema:givenName Toby
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242474271.34
209 rdf:type schema:Person
210 sg:person.014222663645.77 schema:affiliation https://www.grid.ac/institutes/grid.416266.1
211 schema:familyName Siddiqui
212 schema:givenName Moneeza K.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014222663645.77
214 rdf:type schema:Person
215 sg:person.014366020547.03 schema:affiliation https://www.grid.ac/institutes/grid.4305.2
216 schema:familyName Morris
217 schema:givenName Andrew D.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014366020547.03
219 rdf:type schema:Person
220 sg:person.0602377336.44 schema:affiliation Ncc7675ea185e43a5afd87996c508d6e1
221 schema:familyName Kennedy
222 schema:givenName Gwen
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602377336.44
224 rdf:type schema:Person
225 sg:person.0666420000.47 schema:affiliation https://www.grid.ac/institutes/grid.416266.1
226 schema:familyName Pearson
227 schema:givenName Ewan R.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666420000.47
229 rdf:type schema:Person
230 sg:person.0723764061.89 schema:affiliation https://www.grid.ac/institutes/grid.416266.1
231 schema:familyName Carr
232 schema:givenName Fiona
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723764061.89
234 rdf:type schema:Person
235 sg:pub.10.1038/sj.eye.6701476 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037499859
236 https://doi.org/10.1038/sj.eye.6701476
237 rdf:type schema:CreativeWork
238 https://app.dimensions.ai/details/publication/pub.1076395449 schema:CreativeWork
239 https://doi.org/10.1001/archopht.1996.01100140281004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036647745
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1001/jama.1988.03410190112033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018139492
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1001/jama.1993.03510140074032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010028810
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/j.ajo.2005.11.038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008928273
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/j.ajo.2008.07.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052563999
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/j.jdiacomp.2007.07.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013261467
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/j.ophtha.2008.10.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009145982
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.ophtha.2010.02.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003458685
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/j.ophtha.2011.01.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027031594
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/j.ophtha.2011.12.039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024267022
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/j.ophtha.2012.04.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029793783
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/j.ophtha.2014.12.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050307473
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/s0140-6736(10)60319-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020486660
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1016/s0161-6420(00)00600-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026346280
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/s0161-6420(95)30894-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008747998
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1016/s0161-6420(98)91020-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021744248
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1034/j.1600-0420.1999.770211.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012706771
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1056/nejm200010193431603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039043506
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1073/pnas.1514213113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024434288
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1076/opep.6.1.61.1563 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030063151
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1080/01621459.1999.10474144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058305593
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1093/ije/dyx140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090564017
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1111/j.1365-2796.2010.02258.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007524624
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1111/j.1464-5491.2005.01603.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038109955
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1161/01.atv.0000222983.73369.c8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048190623
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1177/003591576505800503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1076395449
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1185/03007995.2010.482503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051289022
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1517/14728214.12.4.591 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045744845
294 rdf:type schema:CreativeWork
295 https://doi.org/10.2337/dc11-1909 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034742328
296 rdf:type schema:CreativeWork
297 https://doi.org/10.2337/dc12-2392 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048805500
298 rdf:type schema:CreativeWork
299 https://doi.org/10.2337/diabetes.53.11.2883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014324731
300 rdf:type schema:CreativeWork
301 https://doi.org/10.2337/diacare.26.9.2653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040313931
302 rdf:type schema:CreativeWork
303 https://doi.org/10.3233/jad-122254 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078686348
304 rdf:type schema:CreativeWork
305 https://www.grid.ac/institutes/grid.416266.1 schema:alternateName Ninewells Hospital
306 schema:name Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, University of Dundee School of Medicine, Ninewells Hospital and Medical School, DD1 9SY, Dundee, UK
307 rdf:type schema:Organization
308 https://www.grid.ac/institutes/grid.418019.5 schema:alternateName GlaxoSmithKline (United States)
309 schema:name Worldwide Epidemiology, GlaxoSmithKline, Collegeville, PA, USA
310 rdf:type schema:Organization
311 https://www.grid.ac/institutes/grid.418236.a schema:alternateName GlaxoSmithKline (United Kingdom)
312 schema:name GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, UK
313 rdf:type schema:Organization
314 https://www.grid.ac/institutes/grid.419047.f schema:alternateName Arkema (United States)
315 schema:name Alternative Discovery and Development, Research & Development, GlaxoSmithKline, King of Prussia, PA, USA
316 rdf:type schema:Organization
317 https://www.grid.ac/institutes/grid.4305.2 schema:alternateName University of Edinburgh
318 schema:name Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
319 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...